The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study

The authors have done commendable work in exploring the utility of a comprehensive viscoelastic test for assessment of the coagulation cascade in Coronavirus disease 2019 (COVID-19) patients. This article published in your esteemed journal in November 2021 The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study found hypercoagulability in most of the patients at Intensive Care Unit (ICU) admission and also noted a persistently increased fibrin contribution to clot strength. However, we would like to comment upon a few points which may be of importance to the readers.

Automated summary

The authors have conducted a commendable study on the utility of comprehensive viscoelastic tests in assessing the coagulation cascade in COVID-19 patients. The study found hypercoagulability in ICU-admitted COVID-19 patients and observed a persistent increase in fibrin contribution to clot strength.